Literature DB >> 10686032

Evaluation of the antibody specificities of human convalescent-phase sera against the attachment (G) protein of human respiratory syncytial virus: influence of strain variation and carbohydrate side chains.

C Palomo1, P A Cane, J A Melero.   

Abstract

The C-terminal third of the attachment protein (G) of several human respiratory syncytial virus isolates was obtained as either a glycosylated protease-resistant fragment of the purified protein or a nonglycosylated GST fusion protein expressed in bacteria. The reactivity of human convalescent-phase sera with both forms of the protein segment was evaluated in immunoblots. While all serum samples reacted with the mature intact protein of the different isolates, only certain samples reacted with the nonglycosylated C-terminal segment of some viral isolates. The number of human serum samples reacting with the glycosylated C-terminal fragment was even more limited. These results highlight the heterogeneity of the human antibody response against epitopes located in the C-terminal hypervariable region of the G molecule and the influence of carbohydrate side chains for expression of these epitopes. We also have analysed the specificities of human sera by competitive enzyme-linked immunosorbent assay with murine monoclonal antibodies (MAbs). Most human serum samples inhibited virus binding of MAbs that recognised conserved or group-specific epitopes of the G protein, while only a limited fraction of those samples inhibited binding of MAbs that recognised strain-specific epitopes. These results are discussed in terms of the antibody repertoire induced after human respiratory syncytial virus infection and the relevance of escape mechanisms to preexisting antibodies for the evolution of this virus. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10686032

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  34 in total

1.  Antibody response to the central unglycosylated region of the respiratory syncytial virus attachment protein in mice.

Authors:  Yoshihiko Murata; Seana C Catherman
Journal:  Vaccine       Date:  2012-06-19       Impact factor: 3.641

2.  Conservation of G-Protein Epitopes in Respiratory Syncytial Virus (Group A) Despite Broad Genetic Diversity: Is Antibody Selection Involved in Virus Evolution?

Authors:  Alfonsina Trento; Leyda Ábrego; Rosa Rodriguez-Fernandez; Maria Isabel González-Sánchez; Felipe González-Martínez; Adriana Delfraro; Juan M Pascale; Juan Arbiza; José A Melero
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

3.  Genetic variability and molecular evolution of the human respiratory syncytial virus subgroup B attachment G protein.

Authors:  Kalina T Zlateva; Philippe Lemey; Elien Moës; Anne-Mieke Vandamme; Marc Van Ranst
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Genetic analyses reveal differences in the VP7 and VP4 antigenic epitopes between human rotaviruses circulating in Belgium and rotaviruses in Rotarix and RotaTeq.

Authors:  Mark Zeller; John T Patton; Elisabeth Heylen; Sarah De Coster; Max Ciarlet; Marc Van Ranst; Jelle Matthijnssens
Journal:  J Clin Microbiol       Date:  2011-12-21       Impact factor: 5.948

5.  Serum mannose-binding lectin levels are linked with respiratory syncytial virus (RSV) disease.

Authors:  Lucas Zimon Giacomini Ribeiro; Ralph A Tripp; Lívia Maria Gonçalves Rossi; Patrícia Vianna Bonini Palma; Jonny Yokosawa; Orlando Cesar Mantese; Thelma Fátima Mattos Oliveira; Lysa Luiz Nepomuceno; Divina Aparecida Oliveira Queiróz
Journal:  J Clin Immunol       Date:  2007-10-20       Impact factor: 8.317

6.  Influence of respiratory syncytial virus strain differences on pathogenesis and immunity.

Authors:  José A Melero; Martin L Moore
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

7.  Recombinant respiratory syncytial viruses lacking the C-terminal third of the attachment (G) protein are immunogenic and attenuated in vivo and in vitro.

Authors:  Matthew B Elliott; Karin S Pryharski; Qingzhong Yu; Christopher L Parks; Todd S Laughlin; C Kanta Gupta; Robert A Lerch; Valerie B Randolph; Natisha A LaPierre; Kristen M Heers Dack; Gerald E Hancock
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

8.  Genetic variability of group A human respiratory syncytial virus strains circulating in Germany from 1998 to 2007.

Authors:  Janine Reiche; Brunhilde Schweiger
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

9.  Direct whole-genome deep-sequencing of human respiratory syncytial virus A and B from Vietnamese children identifies distinct patterns of inter- and intra-host evolution.

Authors:  Lien Anh Ha Do; Andreas Wilm; H Rogier van Doorn; Ha Minh Lam; Shuzhen Sim; Rashmi Sukumaran; Anh Tuan Tran; Bach Hue Nguyen; Thi Thu Loan Tran; Quynh Huong Tran; Quoc Bao Vo; Nguyen Anh Tran Dac; Hong Nhien Trinh; Thi Thanh Hai Nguyen; Bao Tinh Le Binh; Khanh Le; Minh Tien Nguyen; Quang Tung Thai; Thanh Vu Vo; Ngoc Quang Minh Ngo; Thi Kim Huyen Dang; Ngoc Huong Cao; Thu Van Tran; Lu Viet Ho; Jeremy Farrar; Menno de Jong; Swaine Chen; Niranjan Nagarajan; Juliet E Bryant; Martin L Hibberd
Journal:  J Gen Virol       Date:  2015-12       Impact factor: 3.891

10.  Positive selection results in frequent reversible amino acid replacements in the G protein gene of human respiratory syncytial virus.

Authors:  Viviane F Botosso; Paolo M de A Zanotto; Mirthes Ueda; Eurico Arruda; Alfredo E Gilio; Sandra E Vieira; Klaus E Stewien; Teresa C T Peret; Leda F Jamal; Maria I de M C Pardini; João R R Pinho; Eduardo Massad; Osvaldo A Sant'anna; Eddie C Holmes; Edison L Durigon
Journal:  PLoS Pathog       Date:  2009-01-02       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.